Any individual that has had challenges with reaching their personal weight goals may potentially benefit from GLP-1 medications
The body adapts to the new signaling patterns, and normal function returns
Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [9-, 33- and 113- fold the maximum recommended human dose (MRHD) of RYBELSUS 14 mg, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (3-, 9- and 33-fold MRHD) were administered to the females
Visual Inspection of Injectable Drug Products
Also on today's show: Pizza Hut is struggling and betting on nostalgia to save itself (we say bring back the red cups and jukeboxes)
& Larijani, B